Morten Harboe
Volume:
67 - Edition:
1 -
Jan/Feb/Mar -
1999
Structure of the 15th international leprosy congress
Morten Harboe
Volume:
68 - Edition:
1 -
Jan/Feb/Mar -
2000
Clarification to Rada-Schlaefli, et al.
Anand Iyer;
Morten Harboe
Volume:
68 - Edition:
3 -
Jul/Aug/Sep -
2000
Leprosy at a turning point?
Morten Harboe
Volume:
68 - Edition:
4 -
Oct/Nov/Dec -
2000
Robert N. Mshana, M.D., Ph.D. 1954-2000
Morten Harboe
Volume:
64 - Edition:
4 -
Oct/Nov/Dec -
1996
Low rates of detection of Mycobacterial secretory antigen 85 in sera of untreated leprosy patients
Nerges F. Mistry;
Anand Iyer;
Morten Harboe;
Noshir H. Antia
Volume:
60 - Edition:
3 -
Jul/Aug/Sep -
1992
The significance of proteins actively secreted by Mycobacterium tuberculosis in relation to immunity and complications of mycobacterial diseases
Morten Harboe
Volume:
56 - Edition:
4 -
Oct/Nov/Dec -
1988
In Vitro synthesis of antimycobacterial antibodies with different specificities in various tissues of leprosy patients
Rudy F. M. Lai A Fat1;
Morten Harboe3;
Jimmy C. Chan Pin Jin2;
Martina M. C. Diesselhoff-den Dulk4;
Ralph van Furth5
Volume:
55 - Edition:
4 -
Oct/Nov/Dec -
1987
Antibodies to a synthetic analog of phenolic glycolipid-i of Mycobacterium leprae in healthy household contacts of patients with leprosy
Suzanne Menzel;
Morten Harboe;
Helén Bergsvik;
Patrick J. Brennan
Volume:
53 - Edition:
1 -
Jan/Feb/Mar -
1985
Leprosy in a mangabey monkey-naturally acquired infection
Wayne M. Meyers;
Gerald P. Walsh;
Harriet L. Brown;
Chapman H. Binford;
George D. Imes Jr.;
Ted L. Hadfield;
Charles J. Schlagel;
Yukiko Fukunishi;
Peter J. Gerone;
Robert H. Wolf;
Bobby J. Gormus;
Louis N. Martin;
Morten Harboe;
Tamotsu Imaeda
Volume:
51 - Edition:
3 -
Jul/Aug/Sep -
1983
Relation between anti-Mycobacterium leprae antibody activity and clinical features in borderline tuberculoid (BT) Leprosy
Els J. M. Touw Langendijk;
Titia Warndorff van Diepen;
Morten Harboe;
Ayele Belehu
Volume:
51 - Edition:
3 -
Jul/Aug/Sep -
1983
Effect of treatment on antibody activity against Mycobacterium leprae antigen 7 intuberculoid leprosy
John Sverre Dahle;
Titia Warndorff van Diepen;
Els J. M. Touw Langendijk;
Morten Harboe;
Ayele Belehu
Volume:
51 - Edition:
1 -
Jan/Feb/Mar -
1983
Immune responses to bovine neural antigens in leprosy patients. I. Absence of antibodies to an isolated myelin protein
Robert N. Mshana;
Morten Harboe;
Gerald L. Stoner;
R. A. C. Hughes;
M. Kadlubowski;
Ayele Belehu
Volume:
50 - Edition:
3 -
Jul/Aug/Sep -
1982
Class specific anti-Mycobacterium leprae antibody assay in lepromatous leprosy (BL-LL)patients during the first two tofour years of DDS treatment
Reidar Melsom;
Morten Harboe;
Ben Naafs
Volume:
50 - Edition:
3 -
Jul/Aug/Sep -
1982
Thymus dependent lymphocytes in leprosy. I. T lymphocyte subpopulations defined by monoclonal antibodies
Robert N. Mshana;
Abebe Haregewoin;
Morten Harboe;
Ayele Belehu
Volume:
50 - Edition:
3 -
Jul/Aug/Sep -
1982
Significance of antibody studies in leprosy and experimental models of the disease
Morten Harboe
Volume:
49 - Edition:
2 -
Apr/May/Jun -
1981
Demonstration of antibodies reacting with different determinants on Mycobacterium leprae antigen 7
Morten Harboe;
Otto Closs;
Liv Jorun Reitan;
Philip Draper
Volume:
49 - Edition:
1 -
Jan/Feb/Mar -
1981
A claim for a Mycobacterium leprae specific antigen
Morten Harboe;
Otto Closs
Volume:
48 - Edition:
2 -
Apr/May/Jun -
1980
Immunological aspects of leprosy: ten years' activity at the Armauer Hansen Research Institute and prospects for further work
Morten Harboe